Trials / Completed
CompletedNCT06617390
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatment: a Multi-center, Non-interventional and Retrospective Real-world Study (RECAP)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,041 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will retrospectively collect data of patients with advanced non-small cell lung cancer who have received at least 2 line treatment to investigate treatment patterns, relevant outcomes, and biomarkers detection patterns in Chinese patients with Actionable Genomic Alterations (AGA) or non-AGA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No drug | This is a non-interventional study and no study drug will be provided. |
Timeline
- Start date
- 2024-08-15
- Primary completion
- 2025-01-26
- Completion
- 2025-07-30
- First posted
- 2024-09-27
- Last updated
- 2025-08-03
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06617390. Inclusion in this directory is not an endorsement.